What does a prescription assessment establish?
An assessment is a chance for a clinician to review a health question, medical history and current medicines. It can end with a decision against treatment. Access to a review doesn’t mean everyone will qualify for care.
Promise Peptides offers BPC-157 prescription care. Its website is mypromise.com; care is limited to U.S. residents. A licensed U.S. clinician reviews your history and makes the prescribing decision; you may not qualify. The compounded medicines used in this care aren’t FDA-approved.
That answers a question about a prescription route. It doesn’t fill the gaps in BPC-157’s human repair evidence. Both parts deserve a look, even when one answer sounds more reassuring than the other.
Does compounded mean approved?
No. Compounding means making or mixing a medicine for a particular need. The FDA explains that compounded drugs are not FDA-approved. It doesn’t check their safety, effectiveness and quality before marketing as it does with approved products.
We find it useful to name the exact product. An approved medicine, a compounded preparation and material labeled for lab research can share a familiar ingredient name. The name alone doesn’t make them equivalent.
Why do older pages call BPC-157 Category 2?
On the FDA’s page current as of April 22, 2026, BPC-157 is listed as nominated but withdrawn. It’s no longer in that page’s Category 2 table. The people who submitted the requests took them back.
That isn’t clearance, approval for compounding or a move to Category 1. The FDA still prints safety concerns beside the entry. Its page gives no date for BPC-157’s move between tables, so the page’s update date can’t serve as one.
What about “research use only”?
That label doesn’t establish FDA approval or benefit in people. The BPC-157 review discusses the limited human evidence and concerns about unregulated availability. A label can’t supply missing safety data.
For a clinical conversation, we’d keep the questions concrete: what evidence fits this condition, what harms are known, and what follow-up would be needed? There’s room to discuss waiting as well as treatment.